Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2000 1
2002 2
2005 2
2006 2
2007 3
2008 7
2009 6
2010 5
2011 3
2012 8
2013 7
2014 10
2015 13
2016 9
2017 13
2018 16
2019 19
2020 24
2021 21
2022 15
2023 38
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for bench lu
Search for Benchu Lu instead (1 results)
A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?
Gupta M, Karthikeyan G, Choudhury PS, Babu Koyyala VP, Sharma M, Jain P, Talwar V, Singh A, Rawal S. Gupta M, et al. Cancer Invest. 2020 Sep;38(8-9):486-492. doi: 10.1080/07357907.2020.1811301. Epub 2020 Sep 14. Cancer Invest. 2020. PMID: 32804008 Review.
Endo-radioligand therapy with Lutetium 177 prostate-specific membrane antigen 617 (Lu-177 PSMA) based on the Theranostic concept has emerged as a promising tool among these. ...
Endo-radioligand therapy with Lutetium 177 prostate-specific membrane antigen 617 (Lu-177 PSMA) based on the Theranostic concept has …
CGRP and migraine: from bench to bedside.
Edvinsson L. Edvinsson L. Rev Neurol (Paris). 2021 Sep;177(7):785-790. doi: 10.1016/j.neurol.2021.06.003. Epub 2021 Jul 15. Rev Neurol (Paris). 2021. PMID: 34275653 Free article. Review.
One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [(177)Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting.
Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P, Asopa RV, Sonawane G, Nabar S, Shimpi H, Chandak A, Vimalnath KV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Shrikhande SV, Sirohi B, Dash A, Banerjee S. Basu S, et al. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211. eCollection 2020. Am J Nucl Med Mol Imaging. 2020. PMID: 32929396 Free PMC article. Review.
Initiated in 2010 at our centre, the PRRT programme is a perfect example of affordable quality health care delivery, with indigenous production of the radionuclide ((177)Lu) in the reactor and subsequent radiolabeling of the radiopharmaceutical ([(177)Lu]Lu-D …
Initiated in 2010 at our centre, the PRRT programme is a perfect example of affordable quality health care delivery, with indigenous product …
Role of lysosomes in physiological activities, diseases, and therapy.
Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. Zhang Z, et al. J Hematol Oncol. 2021 May 14;14(1):79. doi: 10.1186/s13045-021-01087-1. J Hematol Oncol. 2021. PMID: 33990205 Free PMC article. Review.
Based on these findings, a series of therapeutic methods targeting lysosomal proteins and processes have been developed from bench to bedside. In a word, present researches corroborate lysosomes to be pivotal organelles for understanding pathology of atherosclerosis, neuro …
Based on these findings, a series of therapeutic methods targeting lysosomal proteins and processes have been developed from bench to …
From bench to bedside: (64)Cu/(177)Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications.
Gnesin S, Chouin N, Cherel M, Dunn SM, Schaefer N, Faivre-Chauvet A, Prior JO, Delage JA. Gnesin S, et al. EJNMMI Res. 2023 Jun 14;13(1):59. doi: 10.1186/s13550-023-01010-4. EJNMMI Res. 2023. PMID: 37314509 Free PMC article.
This study reports the mice-to-human dosimetry extrapolation of (64)Cu/(177)Lu 1C1m-Fc anti-TEM-1 for theranostic application in soft-tissue sarcomas. ...Dosimetry properties for the [(64)Cu]Cu-1C1m-Fc are suitable for a diagnostic in-human use. The therapeutic application …
This study reports the mice-to-human dosimetry extrapolation of (64)Cu/(177)Lu 1C1m-Fc anti-TEM-1 for theranostic application in soft …
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [(177)Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside.
Arbuznikova D, Klotsotyra A, Uhlmann L, Domogalla LC, Steinacker N, Mix M, Niedermann G, Spohn SKB, Freitag MT, Grosu AL, Meyer PT, Gratzke C, Eder M, Zamboglou C, Eder AC. Arbuznikova D, et al. Theranostics. 2024 Apr 8;14(6):2560-2572. doi: 10.7150/thno.93249. eCollection 2024. Theranostics. 2024. PMID: 38646643 Free PMC article.
In the in vivo therapy study, LNCaP tumor-bearing BALB/c nu/nu mice were irradiated once with 2 Gy X-ray EBRT and injected with 40 MBq [(177)Lu]Lu-PSMA-617 after 4 h or received single or no treatment (n = 10 each). Tumor-absorbed doses by [(177)Lu]Lu- …
In the in vivo therapy study, LNCaP tumor-bearing BALB/c nu/nu mice were irradiated once with 2 Gy X-ray EBRT and injected with 40 MBq [(177 …
Opportunities and obstacles for deep learning in biology and medicine.
Ching T, Himmelstein DS, Beaulieu-Jones BK, Kalinin AA, Do BT, Way GP, Ferrero E, Agapow PM, Zietz M, Hoffman MM, Xie W, Rosen GL, Lengerich BJ, Israeli J, Lanchantin J, Woloszynek S, Carpenter AE, Shrikumar A, Xu J, Cofer EM, Lavender CA, Turaga SC, Alexandari AM, Lu Z, Harris DJ, DeCaprio D, Qi Y, Kundaje A, Peng Y, Wiley LK, Segler MHS, Boca SM, Swamidass SJ, Huang A, Gitter A, Greene CS. Ching T, et al. J R Soc Interface. 2018 Apr;15(141):20170387. doi: 10.1098/rsif.2017.0387. J R Soc Interface. 2018. PMID: 29618526 Free PMC article. Review.
Nonetheless, we foresee deep learning enabling changes at both bench and bedside with the potential to transform several areas of biology and medicine....
Nonetheless, we foresee deep learning enabling changes at both bench and bedside with the potential to transform several areas of bio …
Synucleinopathies from bench to bedside.
Puschmann A, Bhidayasiri R, Weiner WJ. Puschmann A, et al. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S24-7. doi: 10.1016/S1353-8020(11)70010-4. Parkinsonism Relat Disord. 2012. PMID: 22166445 Review.
210 results